These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8858786)

  • 1. Design and analysis of intra-subject variability in cross-over experiments.
    Chinchilli VM; Esinhart JD
    Stat Med; 1996 Aug; 15(15):1619-34. PubMed ID: 8858786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomization as a basis for inference in noninferiority trials.
    Wiens BL
    Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of multiple-dose bioequivalence studies.
    Chinchilli VM; Esinhart JD; Barr WH
    J Biopharm Stat; 1994 Nov; 4(3):423-35. PubMed ID: 7881454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small sample inference for fixed effects from restricted maximum likelihood.
    Kenward MG; Roger JH
    Biometrics; 1997 Sep; 53(3):983-97. PubMed ID: 9333350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tests for inter-subject and total variabilities under crossover designs.
    Lee Y; Shao J; Chow SC; Wang H
    J Biopharm Stat; 2002 Nov; 12(4):503-34. PubMed ID: 12477072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Likelihood inference on the relative risk in split-cluster designs.
    Shoukri MM; Colak D; Donner A
    Clin Trials; 2011 Feb; 8(1):37-47. PubMed ID: 21335588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple analysis of a simple crossover trial with a dichotomous outcome measure.
    Schouten H; Kester A
    Stat Med; 2010 Jan; 29(2):193-8. PubMed ID: 19882677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-step procedure for assessing bioequivalence in the general mixed model framework.
    Vuorinen J; Turunen J
    Stat Med; 1996 Dec; 15(24):2635-55. PubMed ID: 8981677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size calculation for the Power Model for dose proportionality studies.
    Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
    Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CrossOver: an algorithm for the construction of efficient cross-over designs.
    John JA; Russell KG; Whitaker D
    Stat Med; 2004 Sep; 23(17):2645-58. PubMed ID: 15316948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.
    Panhard X; Mentré F
    Stat Med; 2005 May; 24(10):1509-24. PubMed ID: 15761916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blinded sample size reassessment in non-inferiority and equivalence trials.
    Friede T; Kieser M
    Stat Med; 2003 Mar; 22(6):995-1007. PubMed ID: 12627414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach for outliers in a bioavailability/bioequivalence study.
    Liao JJ
    J Biopharm Stat; 2007; 17(3):393-405. PubMed ID: 17479389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossover trials with a cumulative response.
    Walter SD
    J Biopharm Stat; 1997 Nov; 7(4):649-66. PubMed ID: 9358336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical methods for active extension trials.
    Hu Z; Follmann D
    Stat Med; 2007 May; 26(12):2433-48. PubMed ID: 17066400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The analysis of incomplete data in the three-period two-treatment cross-over design for clinical trials.
    Richardson BA; Flack VF
    Stat Med; 1996 Jan; 15(2):127-43. PubMed ID: 8614750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The assessment of individual and population bioequivalence.
    Chinchilli VM
    J Biopharm Stat; 1996 Mar; 6(1):1-14. PubMed ID: 8838775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed-effect versus random-effect models for evaluating therapeutic preferences.
    Lee Y
    Stat Med; 2002 Aug; 21(16):2325-30. PubMed ID: 12210617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inference of equivalence for the ratio of two normal means with unspecified variances.
    Xu S; Hua SY; Menton R; Barker K; Menon S; D'Agostino RB
    J Biopharm Stat; 2014; 24(6):1264-79. PubMed ID: 25033269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.